261 related articles for article (PubMed ID: 35788349)
1. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
2. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
3. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease.
Ajmera V; Nguyen K; Tamaki N; Sharpton S; Bettencourt R; Loomba R
Therap Adv Gastroenterol; 2022; 15():17562848221093869. PubMed ID: 35509420
[TBL] [Abstract][Full Text] [Related]
5. Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.
Inada K; Tamaki N; Kurosaki M; Kirino S; Yamashita K; Hayakawa Y; Higuchi M; Takaura K; Kaneko S; Maeyashiki C; Yasui Y; Tsuchiya K; Nakanishi H; Izumi N
J Gastroenterol Hepatol; 2022 Sep; 37(9):1726-1731. PubMed ID: 35587726
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Tamaki N; Imajo K; Sharpton S; Jung J; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
Hepatology; 2022 Mar; 75(3):661-672. PubMed ID: 34496054
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
[TBL] [Abstract][Full Text] [Related]
8. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
9. MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.
Noureddin N; Ajmera V; Bergstrom J; Bettencourt R; Huang DQ; Siddiqi H; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
Aliment Pharmacol Ther; 2023 Nov; 58(9):856-865. PubMed ID: 37694993
[TBL] [Abstract][Full Text] [Related]
10. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.
Gidener T; Ahmed OT; Larson JJ; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1915-1924.e6. PubMed ID: 33010409
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
[TBL] [Abstract][Full Text] [Related]
12. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
Qu Y; Middleton MS; Loomba R; Glaser KJ; Chen J; Hooker JC; Wolfson T; Covarrubias Y; Valasek MA; Fowler KJ; Zhang YN; Sy E; Gamst AC; Wang K; Mamidipalli A; Schwimmer JB; Song B; Reeder SB; Yin M; Ehman RL; Sirlin CB
Eur Radiol; 2021 Nov; 31(11):8408-8419. PubMed ID: 33899143
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK; Bergstrom J; Loomba R; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Truong E; Yang JD; Noureddin M; Allen AM; Loomba R; Ajmera V
Hepatology; 2023 Dec; 78(6):1858-1866. PubMed ID: 37203233
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic Steatohepatitis.
Tang H; Li J; Zinker B; Boehm S; Mauer A; Rex-Rabe S; Glaser KJ; Fronheiser M; Bradstreet T; Nakao Y; Petrone T; Pena A; Villano M; Chow P; Malhi H; Charles ED; Hayes W; Ehman RL; Du S; Yin M
J Magn Reson Imaging; 2022 Sep; 56(3):712-724. PubMed ID: 35092323
[TBL] [Abstract][Full Text] [Related]
16. Predicting gastroesophageal varices through spleen magnetic resonance elastography in pediatric liver fibrosis.
Yoon H; Shin HJ; Kim MJ; Han SJ; Koh H; Kim S; Lee MJ
World J Gastroenterol; 2019 Jan; 25(3):367-377. PubMed ID: 30686904
[TBL] [Abstract][Full Text] [Related]
17. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
[TBL] [Abstract][Full Text] [Related]
18. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
Tang A; Dzyubak B; Yin M; Schlein A; Henderson WC; Hooker JC; Delgado TI; Middleton MS; Zheng L; Wolfson T; Gamst A; Loomba R; Ehman RL; Sirlin CB
Eur Radiol; 2022 May; 32(5):2937-2948. PubMed ID: 34928415
[TBL] [Abstract][Full Text] [Related]
19. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Ajmera V; Liu A; Bettencourt R; Dhar D; Richards L; Loomba R
Aliment Pharmacol Ther; 2021 Jul; 54(1):68-77. PubMed ID: 33975381
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
